![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Alberti Paola Cortinovis Diego Frigeni Barbara Bidoli Paolo Cavaletti Guido
Publisher: Future Medicine
ISSN: 1758-1869
Source: Pain Management, Vol.3, Iss.6, 2013-11, pp. : 417-419
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Triple reuptake inhibitors reduce neuropathic pain
EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 19, Iss. 3, 2015-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ethoxyquin prevents chemotherapy‐induced neurotoxicity via Hsp90 modulation
ANNALS OF NEUROLOGY, Vol. 74, Iss. 6, 2013-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Kılınç Muhammed Livanelioğlu Aye Yıldırım Sibel Aksu Tan Ersin
Journal of Rehabilitation Medicine, Vol. 46, Iss. 5, 2014-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States
PAIN MEDICINE, Vol. 16, Iss. 11, 2015-11 ,pp. :